Martin Madaus - Oct 20, 2023 Form 4 Insider Report for STANDARD BIOTOOLS INC. (LAB)

Role
Director
Signature
/s/ Martin D. Madaus by Agnieszka Gallagher, Attoney-in-Fact
Stock symbol
LAB
Transactions as of
Oct 20, 2023
Transactions value $
$3,998
Form type
4
Date filed
10/20/2023, 09:30 PM
Previous filing
Jun 16, 2023
Next filing
Jan 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LAB Common Stock Award $4K +1.57K +1.54% $2.54 104K Oct 20, 2023 Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Consists of Restricted Stock Units. Each Restricted Stock Unit represents the right to receive one share of common stock upon vesting. The Restricted Stock Units vest 100% on December 15, 2023. The Reporting Person has deferred settlement of the Restricted Stock Units until the earlier to occur of the Reporting Person's termination of service and a change of control.
F2 The Restricted Stock Units were issued to the Reporting Person, who elected to take Restricted Stock Units in lieu of $4,000 in cash compensation for services as a committee memeber. The share price is based on the Fair Market Value as of the first date of quarterly trading window following the date on which the Reporting Person's new committe assignment was approved by the Board.
F3 Represents Restricted Stock Units with respect to which the Reporting Person has deferred settlement as described above.